Tue Feb 1, 2022 – 12:12 pm ESTTue Feb 1, 2022 – 12:12 pm EST
(LifeSiteNews) — Pfizer and BioNTech reportedly plan to seek government approval for a COVID-19 vaccine regimen for children as young as six months, even as controversy rages over the shots for adults and young people alike. Children are at little-to-no risk from COVID-19.
The New York Times reports that the partnered pharmaceutical giants may ask the U.S. Food & Drug Administration (FDA) as soon as Thursday to authorize a dosage for children between six months and four years, with emergency use authorization potentially granted by the end of February.
The Times suggests the push is driven by a “sharp increase” in pediatric COVID cases thanks to the prevalence of the omicron variant, though it acknowledges that “young children tend to do well combating the virus” while “some can get very ill.”
The news comes days after White House COVID czar Dr. Anthony Fauci said the Biden administration wants children younger than 4 to take no less than three shots of the vaccine.
Many Americans continue to harbor serious reservations as to the COVID vaccines’ safety, stemming in large part from the
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
